Key Symposium

In September 2016, thought leaders who have the potential to explore, define, and create bioelectronic medicine convened at the Key Symposium.

Session topics included: Defining Circuits, Cell Biology and Cancer, Molecular Sensing, Clinical Updates, Brain Interfaces, Processing the Future, and Funding the Field. By harnessing the power of technology spanning disciplines from microfluidics to computer processing to molecular technology, we step closer to the promise of bioelectronic medicine — to naturally reproduce a drug’s therapeutic reaction by mobilizing the body’s natural reflexes to develop effective, safe and economical alternatives to pills and injectables.

The symposium concluded with a panel entitled “What Life Will Be Like When We Can Fully Modulate the Nervous System: The Impact on Disease, Drugs, the Healthcare Industry, Personal Freedom, and Privacy.” Moderated by PBS’s science correspondent, Miles O’Brien, and featuring panelists from the Feinstein Institute, Massachusetts Institute of Technology (MIT), Sweden’s Karolinska Institute, and Defense Advanced Research Projects Agency (DARPA), the panel explored the far-reaching benefits and consequences that are likely to accompany the ascent of bioelectronics medicine.

To view the panel discussion, click on the video below.

This symposium was presented by The Feinstein Institute for Medical Research, the Journal of Internal Medicine, the Royal Swedish Academy of Sciences, and The New York Academy of Sciences.